Knee Osteoarthritis Oa clinical trials

Explore recruiting knee osteoarthritis oa clinical trials.

Recruiting knee osteoarthritis oa studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Knee Osteoarthritis Oa trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, two-arm, placebo-controlled, participant and investigator-blinded study investigating the efficacy, safety and tolerability of DFV890 in patients with symptomatic knee osteoarthritis

Germany, Spain, Hungary, Czechia, Romania

Therapeutic exploratory (Phase II) EU CTIS Study details

Repurposed Drug Evaluation for Biological Aging, Pain, and Inflammation Reduction in Osteoarthritis

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Prospective Real-World Evidence Study Evaluating the Effects of Voltaren use on Mobility and Quality of Life

Poland

Phase III and phase IV (Integrated) EU CTIS Study details

Multinational, multicentre, double-blind study to evaluate the efficacy and safety of bovine chondroitin sulfate 800 mg tablets versus marine chondroitin sulfate 800 mg tablets in the treatment of pain and functional impairment due to knee osteoarthritis

Czechia, Hungary, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

J1I-MC-GZBJ: A Master Protocol to Investigate the Efficacy and Safety of LY3437943 Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (TRIUMPH-1); J1I-MC-GOA1: Indication-Specific Appendix (ISA2) for participants with knee osteoarthritis (OA)

Romania, Poland, Hungary, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy and safety of NNC0487-0111 s.c. once-weekly in participants with overweight or obesity, and knee osteoarthritis (AMAZE 5)

Italy, Greece, Spain, Bulgaria, Denmark, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Knee Osteoarthritis Oa trials by city

Knee Osteoarthritis Oa in Toronto Knee Osteoarthritis Oa in Vancouver Knee Osteoarthritis Oa in Montreal Knee Osteoarthritis Oa in Calgary Knee Osteoarthritis Oa in Edmonton Knee Osteoarthritis Oa in Ottawa Knee Osteoarthritis Oa in Winnipeg Knee Osteoarthritis Oa in Quebec City Knee Osteoarthritis Oa in Hamilton Knee Osteoarthritis Oa in Kitchener Knee Osteoarthritis Oa in London Knee Osteoarthritis Oa in Halifax Knee Osteoarthritis Oa in New York Knee Osteoarthritis Oa in Los Angeles Knee Osteoarthritis Oa in Chicago Knee Osteoarthritis Oa in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease